The first stop for professional medicines advice

Primary Care

55 results

Applied filters

Primary care discussions: HRT use in clinical practice

24 April 2024This ‘on the couch’ webinar, the second in a series of two, addressed questions around the challenges faced by pharmacists with HRT decision making.

Patient Group Direction use in Primary Care Networks

8 January 2020Guidance on the legislation and governance required when considering the use of PGDs across a PCN

Information resources for advice on HRT

26 June 2024SPS and other information resources to help healthcare professionals provide advice on the menopause and hormone replacement therapy (HRT) decision making.

Using statins in liver impairment

8 November 2024We outline key clinical considerations when initiating statins in patients with liver disease or liver impairment.

Swallowing difficulties: supporting adherence

20 December 2023Interventions and tools to help improve medication adherence, where swallowing difficulties (capability) have been identified as a factor

Clozapine use in adults with swallowing difficulties

31 May 2023Guidance on clozapine administration including crushing tablets, importance of not missing doses and practical considerations regarding switching formulations

Checking if tablets can be crushed or capsules opened

17 December 2024We suggest information resources and points to consider before crushing tablets or opening capsules.

Checking if medicines can be given with food

17 December 2024Many medicines can be given safely with a spoonful of soft food. Use the suggested resources and clinical considerations to support decision-making.

Reminding to take medicines: supporting adherence

20 December 2023Interventions and tools to help improve medication adherence, where memory issues (capability) have been identified as a factor.

Personalised evidence-based medicine to minimise polypharmacy

4 March 2025A consultant pharmacist used case studies to illustrate a patient-centered approach to deprescribing in patients with problematic polypharmacy.